Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Darzalex
Pharma
Sanofi's Sarclisa SC, delivered by on-body injector, matches IV
Two trials have shown Sanofi's Sarclisa investigational SC delivered from an on-body injector produced similar efficacy and safety as Sarclisa IV.
Kevin Dunleavy
Jun 3, 2025 8:15am
FDA advisors back Darzalex as treatment for early myeloma
May 21, 2025 8:52am
J&J, Pfizer and Roche face FDA questions over data applicability
May 16, 2025 3:52pm
FDA to host first oncology adcomm meeting under Makary
May 8, 2025 11:35am
Sanofi's subQ version of Sarclisa measures up to its IV version
Jan 9, 2025 11:14am
ICER calls out drugmakers over 'unsupported' price hikes
Dec 12, 2024 2:24pm
